ASCENTAGE PHARMA GROUP INTERNATIONAL AAPG

Latest FY: 2025 Healthcare Biotechnology
Market Price $18.68
Market Cap $1.62B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑303.7% YoY
$574.12M
3-Yr CAGR: 39.9%
Net Income ↓-3,655,102.9% YoY
-$1.24B
Net Margin: -216.5%
Free Cash Flow
N/A
FCF Yield: N/A
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
-93.8%
ROA: -31.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (AAPG)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2012 $0.1M $0.0M
FY 2013 $0.0M -100.0% $0.0M $-0.2M
FY 2014 -100.0% $-0.8M -404.9%
FY 2015 $-0.3M +63.8%
FY 2016 $-1.5M -440.9%
FY 2021
FY 2022 $209.7M $156.9M $-882.9M
FY 2023 $222.0M +5.9% $125.9M $-0.1M +100.0%
FY 2024 $142.2M -35.9% $77.8M $-0.0M +54.7%
FY 2025 $574.1M +303.7% $520.0M $-1,242.8M -3,655,102.9% 0.00%
$

Valuation

Market Price $18.68
Market Cap $1.62B
Enterprise Value $1.14B
P/E Ratio N/A
P/B Ratio 1.32
FCF Yield N/A
Dividend Yield 0.00%
Shares Outstanding 93,330,500
%

Profitability & Margins

Gross Margin 90.58%
Operating Margin -9.65%
Net Margin -216.47%
Return on Equity (ROE) -93.83%
Return on Assets (ROA) -31.35%
Asset Turnover 0.14x
Revenue 3-Yr CAGR 39.89%
🛡️

Financial Health & Liquidity

Current Ratio 1.79
Cash Ratio 1.50
Debt / Equity 1.495
Debt / Assets 0.499
Cash & Equivalents $2.46B
Total Debt $1.98B
Book Value / Share $14.19
💧

Cash Flow Efficiency

Operating Cash Flow N/A
Capital Expenditures (CapEx) $27.57M
Free Cash Flow N/A
OCF / Revenue N/A
FCF / Revenue N/A
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $14.19
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $3.96B
Total Liabilities $2.63B
Stockholders' Equity $1.32B
Current Assets $2.94B
Current Liabilities $1.64B